| RS397517989 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Usher syndrome type 2A |
| RS397517990 |
USH2A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Usher syndrome type 2A |
| RS397517991 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS397517994 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Retinitis pigmentosa 39 |
| RS397518003 |
USH2A
|
Health Risk |
Pathogenic |
Rare genetic deafness, USH2A-related disorder |
| RS397518008 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS397518009 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS397518010 |
USH2A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Usher syndrome |
| RS397518011 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS397518012 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Rare genetic deafness |
| RS397518013 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS397518014 |
USH2A;USH2A-AS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS397518015 |
USH2A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Usher syndrome type 2A |
| RS397518017 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS397518018 |
USH2A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Retinitis pigmentosa 39 |
| RS397518021 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Retinitis pigmentosa 39 |
| RS397518022 |
USH2A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Retinitis pigmentosa 39 |
| RS397518023 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Retinitis pigmentosa 39 |
| RS397518025 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS397518026 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Retinitis pigmentosa |
| RS397518029 |
USH2A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Usher syndrome type 2A |
| RS397518030 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS397518032 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS397518036 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Retinitis pigmentosa 39 |
| RS397518039 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa |
| RS397518040 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS397518041 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Retinitis pigmentosa |
| RS397518042 |
USH2A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS397518043 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS397518046 |
USH2A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Retinitis pigmentosa 39 |
| RS397518048 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Usher syndrome |
| RS397518050 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS397518413 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Myhre syndrome, Generalized juvenile polyposis/juvenile polyposis coli |
| RS397518414 |
PCBD1
|
Health Risk |
Pathogenic |
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency, Pterin-4 alpha-carbinolamine dehydratase 1 deficiency |
| RS397518416 |
PCBD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency, Pterin-4 alpha-carbinolamine dehydratase 1 deficiency |
| RS397518417 |
MOCS2
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B |
| RS397518418 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS397518419 |
MOCS1
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Combined molybdoflavoprotein enzyme deficiency |
| RS397518420 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS397518421 |
PLS3
|
Health Risk |
association |
Bone mineral density quantitative trait locus 18, Bone mineral density quantitative trait locus 18 |
| RS397518423 |
PIK3CD
|
Health Risk |
Pathogenic |
Immunodeficiency 14, Inherited Immunodeficiency Diseases |
| RS397518425 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS397518432 |
CHST14
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, musculocontractural type |
| RS397518433 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS397518434 |
GBA1
|
Health Risk |
Likely pathogenic |
Gaucher disease perinatal lethal, Gaucher disease type I |
| RS397518435 |
NT5C3A
|
Health Risk |
Pathogenic |
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency |
| RS397518436 |
NT5C3A
|
Health Risk |
Pathogenic |
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency |
| RS397518437 |
NT5C3A
|
Health Risk |
Pathogenic |
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency |
| RS397518438 |
NT5C3A
|
Health Risk |
Pathogenic |
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency, Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency |
| RS397518439 |
PRKN
|
Health Risk |
Pathogenic |
Autosomal recessive juvenile Parkinson disease 2, Autosomal recessive juvenile Parkinson disease 2 |
| RS397518440 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS397518441 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS397518442 |
STK11
|
Health Risk |
Pathogenic |
Carcinoma of pancreas, Peutz-Jeghers syndrome |
| RS397518443 |
STK11
|
Health Risk |
Pathogenic |
Carcinoma of pancreas, Peutz-Jeghers syndrome |
| RS397518444 |
AMH
|
Health Risk |
Pathogenic |
Persistent mullerian duct syndrome, type I |
| RS397518445 |
MTM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe X-linked myotubular myopathy, Centronuclear myopathy |
| RS397518447 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS397518449 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS397518450 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Inborn genetic diseases |
| RS397518451 |
RPL26
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 11, Diamond-Blackfan anemia 11 |
| RS397518452 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3, Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3 |
| RS397518453 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 20, Amyotrophic lateral sclerosis type 20 |
| RS397518455 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 11, Primary ciliary dyskinesia 11 |
| RS397518456 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 11, Primary ciliary dyskinesia 11 |
| RS397518458 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS397518459 |
SPAG1
|
Health Risk |
Pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 5, Autosomal dominant nocturnal frontal lobe epilepsy 5 |
| RS397518460 |
GMPPA
|
Health Risk |
Pathogenic |
Alacrima, achalasia |
| RS397518461 |
GMPPA
|
Health Risk |
Pathogenic |
Alacrima, achalasia |
| RS397518462 |
GMPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Alacrima, achalasia |
| RS397518463 |
PLS3
|
Health Risk |
association |
Bone mineral density quantitative trait locus 18, Bone mineral density quantitative trait locus 18 |
| RS397518464 |
GJA1
|
Health Risk |
Pathogenic |
Oculodentodigital dysplasia, Oculodentodigital dysplasia |
| RS397518465 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Self-limited epilepsy with centrotemporal spikes |
| RS397518466 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS397518467 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS397518468 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Landau-Kleffner syndrome, Seizure |
| RS397518469 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS397518470 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS397518471 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS397518472 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS397518474 |
HERC2
|
Health Risk |
Pathogenic |
Developmental delay with autism spectrum disorder and gait instability, Developmental delay with autism spectrum disorder and gait instability |
| RS397518475 |
ENPP1
|
Health Risk |
Pathogenic |
Hypopigmentation-punctate palmoplantar keratoderma syndrome, Hypopigmentation-punctate palmoplantar keratoderma syndrome |
| RS397518476 |
ENPP1
|
Health Risk |
Pathogenic |
Hypopigmentation-punctate palmoplantar keratoderma syndrome, Hypopigmentation-punctate palmoplantar keratoderma syndrome |
| RS397518477 |
ENPP1
|
Health Risk |
Pathogenic |
Hypopigmentation-punctate palmoplantar keratoderma syndrome, Hypopigmentation-punctate palmoplantar keratoderma syndrome |
| RS397518478 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS397518479 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS397518480 |
ATP6AP2
|
Health Risk |
Pathogenic |
X-linked parkinsonism-spasticity syndrome, X-linked parkinsonism-spasticity syndrome |
| RS397518481 |
RARB
|
Health Risk |
Pathogenic |
Microphthalmia, syndromic 12 |
| RS397518482 |
RARB
|
Health Risk |
Pathogenic |
Microphthalmia, syndromic 12 |
| RS397518483 |
RARB
|
Health Risk |
Pathogenic |
Microphthalmia, syndromic 12 |
| RS397518484 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS397518485 |
TRAF3IP2
|
Health Risk |
Pathogenic |
Candidiasis, familial |
| RS397704705 |
AP5Z1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 48, Macular dystrophy with or without extraocular features |
| RS397704709 |
AP5Z1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS397704714 |
ABHD12
|
Health Risk |
Pathogenic |
PHARC syndrome, PHARC syndrome |
| RS397704718 |
FAM161A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa |
| RS397704721 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS397704725 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS397704728 |
WDPCP
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 15, Bardet-Biedl syndrome 15 |
| RS397769084 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS397978903 |
UGT1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Crigler-Najjar syndrome, type II |